Estimating the survival benefit of transplantation: avoiding bias by using target trial emulation
Bodies: ERBP
8 / 8 results found
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
Speaker
Patrick Mark, United Kingdom
Panellists
Evangelia Dounousi, Greece
Sokratis Stoumpos, United Kingdom
Moderator
Pantelis Sarafidis, Greece
ERBP